Prostatic Neoplasms

Showing NaN - NaN of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)

Recruiting
  • Prostatic Neoplasms
  • +16 more
  • Birmingham, Alabama
  • +296 more
Jan 18, 2023

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)

Active, not recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Anchorage, Alaska
  • +163 more
Jan 18, 2023

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Docetaxel, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +4 more
  • Mobile, Alabama
  • +214 more
Nov 24, 2022

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Enzalutamide, Placebo)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +2 more
  • Mobile, Alabama
  • +257 more
Nov 22, 2022

Prostatic Tumors Trial in Worldwide (Niraparib)

Active, not recruiting
  • Prostatic Neoplasms
  • Tucson, Arizona
  • +109 more
Aug 2, 2022

Prostatic Tumors Trial in Worldwide (JNJ-80038114)

Not yet recruiting
  • Prostatic Neoplasms
  • Nashville, Tennessee
  • +8 more
Aug 2, 2022

Imperial Prostate 6 - Cancer Histology Artificial Intelligence

Recruiting
  • Prostatic Neoplasms
  • Biopsy & Imaging
  • Coventry, United Kingdom
  • +5 more
Mar 29, 2022

Prostatic Tumors Trial in Worldwide (Enzalutamide, NSAA, LHRHA or Surgical Castration)

Active, not recruiting
  • Prostatic Neoplasms
  • Boston, Massachusetts
  • +81 more
Oct 7, 2021

Prostatic Tumors Trial in Worldwide (Enzalutamide, Conventional NSAA, LHRHA)

Active, not recruiting
  • Prostatic Neoplasms
  • Boston, Massachusetts
  • +68 more
Apr 1, 2021

Prostatic Tumors Trial in London, Ottawa, Toronto (Degarelix)

Terminated
  • Prostatic Neoplasms
  • London, Ontario, Canada
  • +2 more
May 5, 2020

Metastatic Cancer of Prostate: A Study of ZYTIGA Use in

Completed
  • Prostatic Neoplasms
  • Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry
  • Calgary, Alberta, Canada
  • +40 more
Dec 5, 2019

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Completed
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Scottsdale, Arizona
  • +67 more
Jun 30, 2019

Prostatic Tumors, Diagnostic Techniques and Procedures Trial in London (SmartTarget - Biopsy)

Completed
  • Prostatic Neoplasms
  • Diagnostic Techniques and Procedures
  • SmartTarget - Biopsy
  • London, United Kingdom
    University College London
Jan 29, 2019

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (BAY88-8223))

Completed
  • Prostatic Neoplasms
  • Radium-223 dichloride (BAY88-8223)
  • Brugge, Belgium
  • +214 more
Mar 30, 2017

Prostatic Tumors Trial in Worldwide (Placebo, Dasatinib, Docetaxel)

Completed
  • Prostatic Neoplasms
  • Placebo
  • +3 more
  • Mobile, Alabama
  • +185 more
Aug 23, 2016

PRIME - PRostate Imaging for Margin Evaluation

Completed
  • Prostatic Neoplasms
    • London, United Kingdom
      University College Hospital London
    Jun 22, 2016

    Prostatic Tumors Trial in Worldwide (Placebo, Abiraterone acetate, Prednisone/prednisolone)

    Completed
    • Prostatic Neoplasms
    • Placebo
    • +2 more
    • Birmingham, Alabama
    • +127 more
    Apr 10, 2014

    Prostatic Tumors Trial in Worldwide (Docetaxel, Prednisone, Intetumumab)

    Completed
    • Prostatic Neoplasms
    • Birmingham, Alabama
    • +59 more
    Jun 12, 2013

    Prostatic Tumors Trial in Worldwide (Prednisone, sunitinib, Placebo)

    Terminated
    • Prostatic Neoplasms
    • Decatur, Alabama
    • +204 more
    Feb 5, 2013

    Blood Cancer, Breast Cancer, Prostatic Tumors Trial in Stanford, London (Cancer: Thriving and Surviving Online Workshop)

    Completed
    • Blood Cancer
    • +4 more
    • Cancer: Thriving and Surviving Online Workshop
    • Stanford, California
    • +1 more
    Feb 5, 2013

    Hormone-Refractory Prostate Cancer, Prostatic Tumors Trial in Worldwide (YM598)

    Terminated
    • Hormone-Refractory Prostate Cancer
    • Prostatic Neoplasms
    • Anchorage, Alaska
    • +52 more
    Jun 6, 2012

    Prostatic Tumors Trial in Worldwide (Atrasentan)

    Completed
    • Prostatic Neoplasms
    • Homewood,, Alabama
    • +233 more
    Aug 13, 2007